Navigation Links
Regeneron Pharmaceuticals Announces Pricing of Offering of Convertible Senior Notes due October 1, 2016
Date:10/18/2011

ertible note hedge and may enter into additional warrant transactions.  The Company intends to use the remaining net proceeds for general corporate purposes.

The notes, and any shares of the Company's common stock issuable upon conversion of the notes, have not been and will not be registered under the Securities Act, or any state securities law, and may not be offered or sold in the United States or to, or for the account or benefit of, any U.S. persons absent registration under the Securities Act, except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws.  This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, including the notes or any shares of the Company's common stock issuable upon conversion of the notes, nor shall there be any offer, solicitation or sale of any securities, including any notes or any shares of the Company's common stock issuable upon conversion of the notes in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Regeneron Pharmaceuticals, Inc.Regeneron is a fully integrated biopharmaceutical company that discovers, develops, manufacturers, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, which is approved for the treatment of a rare inflammatory condition, Regeneron has completed Phase 3 clinical trials of rilonacept for a new indication and of product candidates EYLEA™ (aflibercept injection; VEGF Trap Eye) in diseases of the eye and ZALTRAP® (aflibercept) (VEGF Trap) in colorectal cancer.  EYLEA is currently under review with U.S. and European regulatory authorities.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibod
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
2. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
3. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
4. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
5. Regeneron Reports Third Quarter 2009 Financial and Operating Results
6. Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
7. Regeneron Announces Presentation at the Deutsche Bank 2009 Biotech Boston Confab
8. BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark
9. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
10. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
11. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 The new report ... (products, applications, techniques, end users and Geography) Global ... 2013 - 2020," indicates that the global DNA ... registering a CAGR of 9.8% from 2014 to ... cost effectiveness over alternative diagnostic techniques are factors ...
(Date:8/28/2014)... 2014  Seres Health, a clinical-stage therapeutics company ... human microbiome, announced today that Dr. David ... and Chief Scientific Officer, will be presenting at ... Chemotherapy (ICAAC). The presentation will highlight the scientific ... of bacterial spores derived from the human microbiome, ...
(Date:8/28/2014)... -- Gateway Analytical announced today that they will ... Global Pharma Manufacturing Summit in Boston, ... Global Pharma Manufacturing Summit offers a networking opportunity ... pharmaceutical manufacturing. The conference is focused on helping ... as the increasing pressure to grow and evolve ...
Breaking Medicine Technology:DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
(Date:8/29/2014)... the Fed reported an increase in industrial production ... 0.4% while manufacturing output progressed to 1.0%. , This ... February this year. Capacity use has increased by more than ... increase that could be attributed to the boost in vehicle ... a measure of slack across the industries. , Output in ...
(Date:8/29/2014)... Only a handful of CPR and basic life ... which are consistent with recent health guidelines, according ... Medicine Australasia , the journal for the Australasian ... recognition and treatment of sudden cardiac arrest are ... of Turkish emergency medicine specialists put together the ...
(Date:8/29/2014)... 2014 As a chiropractic physician and ... that there’s a direct connection between the condition of ... back. "Since conventional shoe inserts and orthotics weren’t satisfying ... my own," he said. , Customizable to a user’s ... for the foot in order to help prevent pain ...
(Date:8/29/2014)... FRIDAY, Aug. 29, 2014 (HealthDay News) -- Researchers have ... in their brains. Dyslexia -- the most commonly ... problems with reading and writing. Previous research showed ... but most of those studies focused only on a ... used functional MRI to analyze how multiple brain regions ...
(Date:8/29/2014)... Angeles (PRWEB) August 29, 2014 ... Radio Today at http://www.blogtalkradio.com/dr-carol-francis/2014/08/29/psychologist-dr-carol-francis-addressing-empty-nest-syndrome .     , Mothers ... years of money, marital bliss, prodding, laughing and ... of the house this week. Relief and ... of “now what.” Dr. Carol Francis ...
Breaking Medicine News(10 mins):Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 2Health News:LeaseQ Announces That Recent Industrial Production Report Spells Good Things For The Equipment Leasing Industry 3Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 3
... MPH, an endocrinologist at Nationwide Children,s Hospital, has developed ... text messages to remind adolescent diabetes patients about their ... Dr. Dyer found an increase in overall treatment adherence ... began developing this pilot study after realizing the potential ...
... Reporter , THURSDAY, July 29 (HealthDay News) -- Although ... and ward off osteoporosis, New Zealand researchers say the supplements ... small increase in the risk for heart attack among older ... researchers suggest that people get their required calcium, if possible, ...
... CD74 is a protein that is expressed in and ... lymphocytes and antigen presenting cells. This protein is known ... immune response. Additionally, Professor Shachar,s lab has previously shown ... of the immune system, and that its stimulation by ...
... important factor, influencing both morbidity and recovery after ... allow early intervention, which may prevent later complications. ... medical evaluations to identify significant weight loss over ... thickness, serum nutritional factor levels and functional measurements ...
... (HCC) is one of the most common cancers ... of the more difficult cancers to treat. It ... A number of dietary compounds possess anti-cancer properties. ... specific targets that control cell proliferation and apoptosis. ...
... clinical medicine are familiar with learning curves, and strategies ... on clinical care. Because similar learning curves have been ... University Medical Center studied the phenomenon in the data ... point to ways to improve the quality of future ...
Cached Medicine News:Health News:Pilot study supports adolescent diabetes patients through personalized text messages 2Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 2Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 3Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 4Health News:How to detect malnutrition in patients effectively? 2Health News:Clinical trials can be improved by managing the learning curve 2Health News:Clinical trials can be improved by managing the learning curve 3
... Vacuum Controller V-800 Efficiently controls vacuum levels ... and off as needed to maintain preset vacuum level ... membrane vacuum pump designed to handle most vacuum applications. ... up to two rotary evaporators Laboratory vacuum ...
... V-500 and water-cooled secondary condenser to trap ... powerful PTFE membrane vacuum pump designed to ... Ideally suited for use with up ... vacuum source for instruments including vacuum ovens, ...
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
... addition to the powerful PTFE membrane vacuum pump ... achieve an ultimate vacuum of 1 mbar or ... For use with vacuum drying ovens ... from lab size up to industrial size rotary ...
Medicine Products: